17,261 trials
Attention Deficit Hyperactivity Disorder
Primary: Change From Baseline in Total AISRS Score at the End of Double-blind Treatment (Week 8) — -17; -17 units on a scale
Acute Myeloid Leukemia
Primary: Complete Remission Rate — 36 percentage of participants
Open-Angle Glaucoma · Ocular Hypertension
Primary: Intraocular Pressure Over 84 Days — 22.0; 22.5; 18.8; 19.4 mmHg
Carcinoma, Non-Small-Cell Lung
Primary: Tumor Response — 13; 19; 5; 1 Participants
Prostate Cancer Metastatic · Castration-resistant Prostate Cancer
Primary: Radiographic Progression Free Survival (rPFS) — 11.1; 9.5 Months — p=0.1465
Lymphangioleiomyomatosis
Primary: Rate of Change in Forced Expiratory Volume in 1 Second in ml/Month — 1.04; 1.66 milliliters per month — p=0.4
Odontalgia · Toothache
Primary: Intra-group VAS Pain Intensity and Maximum Pain Relief — 63; 69; 63; 21 score on a scale
Depressive Disorder, Major
Primary: Change From Baseline in Children's Depression Rating Scale-Revised (CDRS-R) Total Score at 24 Hours Post First Dose (Day 2) — -26.2; -29.6; -31.8; -30.3 Units on a scale…
Graft Vs Host Disease · Graft-versus-host-disease · Acute-graft-versus-host Disease
Primary: Grades II-IV aGVHD — 11 Participants
Essential Tremor
Primary: Change From Baseline Compared to Placebo in TETRAS Performance Subscale Part 4 Upper Limb Tremor Score on Day 29 — -2.31; -1.24 score on a scale — p=0.0491
Influenza · Human
Primary: Immunogenicity Endpoint: Geometric Mean Titer (GMT) Against the A/H1N1, B/Victoria and B/Yamagata Vaccine Strains by Hemagglutination Inhibition (HI) Assay and Against…
Psoriasis · Skin Diseases
Primary: Percent Change From Baseline in Psoriasis Activity and Severity Index (PASI) Score at Week 16 — -17.30; -52.60; -61.20; -63.70 percent change — p=<0.001
Diabetes Mellitus, Type 1
Primary: Change in Symptom Score — 25; 21 score on a scale
Pneumococcal Vaccines
Primary: Percentage of Participants Reporting Solicited Local Reactions Within 7 Days After Vaccination — 42.3; 62.7; 37.7; 48.0 percentage of participants
Healthy Volunteer
Primary: Fasting Gastric Volume as Measured by Single Photon Emission Computed Tomography (SPECT) — 178.8; 191.1 mL